Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs
Published in: Drugs 3/2018

01-03-2018 | Correction

Correction to: Daratumumab: A Review in Relapsed and/or Refractory Multiple Myeloma

Author: Hannah A. Blair

Published in: Drugs | Issue 3/2018

Login to get access

Excerpt

The author has alerted us to the following error in Sect. 4.2.2.1, and the following correction should be noted: …
Metadata
Title
Correction to: Daratumumab: A Review in Relapsed and/or Refractory Multiple Myeloma
Author
Hannah A. Blair
Publication date
01-03-2018
Publisher
Springer International Publishing
Published in
Drugs / Issue 3/2018
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.1007/s40265-018-0873-y

Other articles of this Issue 3/2018

Drugs 3/2018 Go to the issue

Leading Article

Overview of Current Drugs and Molecules in Development for Spinal Muscular Atrophy Therapy

Adis Drug Evaluation

Eculizumab: A Review in Generalized Myasthenia Gravis

Current Opinion

Outcomes, Access, and Cost Issues Involving PCSK9 Inhibitors to Lower LDL-Cholesterol

Adis Drug Evaluation

Landiolol: A Review in Tachyarrhythmias

Review Article

Prevention and Treatment of Chronic Postsurgical Pain: A Narrative Review

AdisInsight Report

Netarsudil Ophthalmic Solution 0.02%: First Global Approval